Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Clinical Data's vilazodone meets depression endpoint

CLDA said vilazodone met the primary endpoint in

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE